2013
DOI: 10.5694/mja13.10735
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of peripheral intravenous catheter‐related bloodstream infections: the need for routine replacement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
5
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 7 publications
0
5
0
Order By: Relevance
“…In different studies, the risk of acquiring BSI was not as high if PVCs were used instead of central lines. [31][32][33] In our ICUs, the pooled mean of the distribution of crude mortality amounted to 18% of PVCR-BSIs cases, compared with 6.67% mortality of with PVC patients that were not infected. In recent studies from Spain and Japan, the mortality rates attributable to PVCR-BSI were 13.2% and 12.9%, respectively.…”
Section: Discussionmentioning
confidence: 87%
“…In different studies, the risk of acquiring BSI was not as high if PVCs were used instead of central lines. [31][32][33] In our ICUs, the pooled mean of the distribution of crude mortality amounted to 18% of PVCR-BSIs cases, compared with 6.67% mortality of with PVC patients that were not infected. In recent studies from Spain and Japan, the mortality rates attributable to PVCR-BSI were 13.2% and 12.9%, respectively.…”
Section: Discussionmentioning
confidence: 87%
“…A prospective study by Stuart et al 18 and commentary by Collignon et al 19 underscore the need for further research targeting blood stream infections (sepsis and severe sepsis in particular) as a primary outcome. Blood stream infections, especially those related to PIVC use, are rare entities overall, with most recent data yielding an estimated rate of 0.5 per 1000 catheter-days.…”
Section: Why You Should Not Routinely Replace Pivcsmentioning
confidence: 99%
“…The Hawthorne effect and strict inclusion and exclusion criteria mean that, while largely free of bias, the outcomes of clinical trials are not generalisable. The retrospective data on PIVC‐associated bloodstream infections reported by Stuart et al and Collignon et al, while methodologically limited, demonstrate the real‐world experience of hundreds of patients 1 , 2 …”
mentioning
confidence: 98%
“…To the Editor : Debate regarding the prevention of peripheral intravenous catheter (PIVC)‐associated bloodstream infection has been enriched by research and letters published in the Journal 1 . ‐ 3 Stuart and colleagues and Collignon and colleagues highlighted an association of long dwell times with PIVC‐associated bloodstream infection 1 , 2 . Rickard and colleagues refer to contrasting high‐level evidence in a Cochrane review 3 , 4 .…”
mentioning
confidence: 99%